Search Medical Condition
Please enter condition
Please choose location

Asthma Clinical Trials

A listing of Asthma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (239) clinical trials

This study will be a double-blind, randomized, placebo controlled, parallel-group study to evaluate the effect of Aclidinium bromide on the cardiovascular safety and COPD exacerbations in patients with moderate to very severe COPD, as defined by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria (GOLD, 2011). The Objectives ...

Phase

A one year, phase 3 study for adults with Asthma who are not well controlled with inhaled corticosteroids.

Phase

Do you have difficult asthma? If you have uncontrolled asthma, you may qualify for a clinical trial evaluation an investigational medication.

Phase N/A

We are looking for individuals 12 years of age and older who have asthma to participate in a research study involving an investigational medication.

Phase N/A

We are looking for healthy individuals ages 12 and older with asthma to participate in a research study involving an FDA-approved asthma medication and an investigational medication.

Phase N/A

We are currently participating in a study to assess the efficacy and safety of different doses of study medication in patients with moderate to severe asthma, using an active control. Patient Inclusion Criteria: Diagnosed with Asthma Persistent asthma for at least 1 year Age 18 or older Using an inhaled ...

Phase

Through this project, we are asking patients with asthma to complete an asthma questionnaire and view a brief educational video. This will take about 20 minutes. After completing the questionnaire, a stipend will be available.

Phase N/A

This clinical trial is provided by Antidote. The purpose of this study is to find out whether the drug is safe Tralokinumab, improved asthma symptoms or asthma attacks in asthmatic patients where standard medication does not hit, relieves.

Phase

The objective of this study is to assess the efficacy and safety of 12 months of treatment with 300 IR of STG320 sublingual tablets compared with placebo in adults and adolescents with HDM-associated allergic rhinitis.

Phase